Abstract

Neuroblastoma is an aggressive, relapse-prone childhood tumor of the sympathetic nervous system that accounts for 15% of pediatric cancer deaths. A distal portion of human chromosome 3p is often deleted in neuroblastoma, this region may contain one or more putative tumor suppressor genes. A 2.54 Mb region at 3p26.3 encompassing the smallest region of deletion pinpointed CHL1 gene, the locus for neuronal cell adhesion molecule close homolog of L1. We found that low CHL1 expression predicted poor outcome in neuroblastoma patients. Here we have used two inducible cell models to analyze the impact of CHL1 on neuroblastoma biology. Over-expression of CHL1 induced neurite-like outgrowth and markers of neuronal differentiation in neuroblastoma cells, halted tumor progression, inhibited anchorage-independent colony formation, and suppressed the growth of human tumor xenografts. Conversely, knock-down of CHL1 induced neurite retraction and activation of Rho GTPases, enhanced cell proliferation and migration, triggered colony formation and anchorage-independent growth, accelerated growth in orthotopic xenografts mouse model. Our findings demonstrate unambiguously that CHL1 acts as a regulator of proliferation and differentiation of neuroblastoma cells through inhibition of the MAPKs and Akt pathways. CHL1 is a novel candidate tumor suppressor in neuroblastoma, and its associated pathways may represent a promising target for future therapeutic interventions.

Original languageEnglish
Pages (from-to)25903-25921
Number of pages19
JournalOncotarget
Volume9
Issue number40
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Neuroblastoma
Genes
Neoplasms
Heterografts
Neuronal Cell Adhesion Molecules
Growth
Nervous System Neoplasms
rho GTP-Binding Proteins
Differentiation Antigens
Sympathetic Nervous System
Human Chromosomes
Neurites
Tumor Suppressor Genes
Cell Movement
Cell Differentiation
Cell Proliferation
Pediatrics
Recurrence

Keywords

  • Apoptosis
  • Autophagy
  • CHL1 gene
  • Differentiation
  • Neuroblastoma

ASJC Scopus subject areas

  • Oncology

Cite this

@article{ab91145edee742ab9923289f22321a31,
title = "CHL1 gene acts as a tumor suppressor in human neuroblastoma",
abstract = "Neuroblastoma is an aggressive, relapse-prone childhood tumor of the sympathetic nervous system that accounts for 15{\%} of pediatric cancer deaths. A distal portion of human chromosome 3p is often deleted in neuroblastoma, this region may contain one or more putative tumor suppressor genes. A 2.54 Mb region at 3p26.3 encompassing the smallest region of deletion pinpointed CHL1 gene, the locus for neuronal cell adhesion molecule close homolog of L1. We found that low CHL1 expression predicted poor outcome in neuroblastoma patients. Here we have used two inducible cell models to analyze the impact of CHL1 on neuroblastoma biology. Over-expression of CHL1 induced neurite-like outgrowth and markers of neuronal differentiation in neuroblastoma cells, halted tumor progression, inhibited anchorage-independent colony formation, and suppressed the growth of human tumor xenografts. Conversely, knock-down of CHL1 induced neurite retraction and activation of Rho GTPases, enhanced cell proliferation and migration, triggered colony formation and anchorage-independent growth, accelerated growth in orthotopic xenografts mouse model. Our findings demonstrate unambiguously that CHL1 acts as a regulator of proliferation and differentiation of neuroblastoma cells through inhibition of the MAPKs and Akt pathways. CHL1 is a novel candidate tumor suppressor in neuroblastoma, and its associated pathways may represent a promising target for future therapeutic interventions.",
keywords = "Apoptosis, Autophagy, CHL1 gene, Differentiation, Neuroblastoma",
author = "Marzia Ognibene and Gabriella Pagnan and Danilo Marimpietri and Davide Cangelosi and Michele Cilli and Benedetti, {Maria Chiara} and Renata Boldrini and Alberto Garaventa and Francesco Frassoni and Alessandra Eva and Luigi Varesio and Vito Pistoia and Annalisa Pezzolo",
year = "2018",
month = "1",
day = "1",
doi = "10.18632/oncotarget.25403",
language = "English",
volume = "9",
pages = "25903--25921",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "40",

}

TY - JOUR

T1 - CHL1 gene acts as a tumor suppressor in human neuroblastoma

AU - Ognibene, Marzia

AU - Pagnan, Gabriella

AU - Marimpietri, Danilo

AU - Cangelosi, Davide

AU - Cilli, Michele

AU - Benedetti, Maria Chiara

AU - Boldrini, Renata

AU - Garaventa, Alberto

AU - Frassoni, Francesco

AU - Eva, Alessandra

AU - Varesio, Luigi

AU - Pistoia, Vito

AU - Pezzolo, Annalisa

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Neuroblastoma is an aggressive, relapse-prone childhood tumor of the sympathetic nervous system that accounts for 15% of pediatric cancer deaths. A distal portion of human chromosome 3p is often deleted in neuroblastoma, this region may contain one or more putative tumor suppressor genes. A 2.54 Mb region at 3p26.3 encompassing the smallest region of deletion pinpointed CHL1 gene, the locus for neuronal cell adhesion molecule close homolog of L1. We found that low CHL1 expression predicted poor outcome in neuroblastoma patients. Here we have used two inducible cell models to analyze the impact of CHL1 on neuroblastoma biology. Over-expression of CHL1 induced neurite-like outgrowth and markers of neuronal differentiation in neuroblastoma cells, halted tumor progression, inhibited anchorage-independent colony formation, and suppressed the growth of human tumor xenografts. Conversely, knock-down of CHL1 induced neurite retraction and activation of Rho GTPases, enhanced cell proliferation and migration, triggered colony formation and anchorage-independent growth, accelerated growth in orthotopic xenografts mouse model. Our findings demonstrate unambiguously that CHL1 acts as a regulator of proliferation and differentiation of neuroblastoma cells through inhibition of the MAPKs and Akt pathways. CHL1 is a novel candidate tumor suppressor in neuroblastoma, and its associated pathways may represent a promising target for future therapeutic interventions.

AB - Neuroblastoma is an aggressive, relapse-prone childhood tumor of the sympathetic nervous system that accounts for 15% of pediatric cancer deaths. A distal portion of human chromosome 3p is often deleted in neuroblastoma, this region may contain one or more putative tumor suppressor genes. A 2.54 Mb region at 3p26.3 encompassing the smallest region of deletion pinpointed CHL1 gene, the locus for neuronal cell adhesion molecule close homolog of L1. We found that low CHL1 expression predicted poor outcome in neuroblastoma patients. Here we have used two inducible cell models to analyze the impact of CHL1 on neuroblastoma biology. Over-expression of CHL1 induced neurite-like outgrowth and markers of neuronal differentiation in neuroblastoma cells, halted tumor progression, inhibited anchorage-independent colony formation, and suppressed the growth of human tumor xenografts. Conversely, knock-down of CHL1 induced neurite retraction and activation of Rho GTPases, enhanced cell proliferation and migration, triggered colony formation and anchorage-independent growth, accelerated growth in orthotopic xenografts mouse model. Our findings demonstrate unambiguously that CHL1 acts as a regulator of proliferation and differentiation of neuroblastoma cells through inhibition of the MAPKs and Akt pathways. CHL1 is a novel candidate tumor suppressor in neuroblastoma, and its associated pathways may represent a promising target for future therapeutic interventions.

KW - Apoptosis

KW - Autophagy

KW - CHL1 gene

KW - Differentiation

KW - Neuroblastoma

UR - http://www.scopus.com/inward/record.url?scp=85047445553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047445553&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.25403

DO - 10.18632/oncotarget.25403

M3 - Article

VL - 9

SP - 25903

EP - 25921

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 40

ER -